Former Health and Human Services secretary, Alex Azar, was instrumental in getting the FDA’s approval to import drugs from Canada to Florida in 2020. He is now the chairman of the board of a Dallas-based company, LifeScience Logistics, which Florida is paying to help manage the drug importation program. Critics are concerned about the potential conflict of interest due to the business relationship. The plan is expected to save the state up to $180 million in the first year by obtaining lower-cost drugs for state agencies. However, hurdles remain, and PhRMA, the drug industry’s major lobbying group, is expected to file a lawsuit to block the program.
Source link
Trump Official Who OK’d Drugs From Canada Chairs Company Behind Florida’s Import Plan
